ELUVIA™ OVER-THE-WIRE Drug-Eluting Vascular Stent System - Peripheral artery stent, drug-eluting - ARTG 459345
Access comprehensive regulatory information for ELUVIA™ OVER-THE-WIRE Drug-Eluting Vascular Stent System - Peripheral artery stent, drug-eluting in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 459345 and sponsored by Boston Scientific Pty Ltd, manufactured by Boston Scientific Corporation in United States of America. The device registration started on August 13, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The ELUVIA™ OVER-THE-WIRE Drug-Eluting Vascular Stent System is intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters (RVD) ranging from 4.0 mm - 6.0 mm.